AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hadley, K. B
Right arrow Articles by Hunt, J. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hadley, K. B
Right arrow Articles by Hunt, J. R
Agricola
Right arrow Articles by Hadley, K. B
Right arrow Articles by Hunt, J. R
American Journal of Clinical Nutrition, Vol. 84, No. 1, 150-155, July 2006
© 2006 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Iron absorption by healthy women is not associated with either serum or urinary prohepcidin1,2,3,4

Kevin B Hadley, LuAnn K Johnson and Janet R Hunt

1 From the US Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND (KBH and JRH) and the University of North Dakota, Grand Forks, ND (LKJ)

Background: Although hepcidin is proposed as a regulator of iron absorption, this has not been assessed in humans.

Objective: Our objective was to assess the relation between serum or urinary prohepcidin and iron absorption in healthy premenopausal women.

Design: The subjects were 28 healthy women aged 22–51 y with normal hemoglobin concentrations (120–152 g/L). Absorption of 0.5 mg Fe with 0.2 µCi 59Fe tracer, both as FeSO4, was measured by whole-body scintillation counting 13 d after oral administration. Fasting blood and urine samples were collected the day of and 16 wk after the absorption measurement. Serum and urinary prohepcidin concentrations were measured by an enzyme-linked immunosorbent assay by using an antibody against amino acid residues 28–47 of the proregion.

Results: Mean (±SD) iron absorption was 36 ± 19% (range: 4–81%), and serum ferritin (geometric x) was 27 µg/L (range: 4–122 µg/L), as commonly observed in healthy premenopausal women. Serum prohepcidin was 196 µg/L (range: 99–376 µg/L) and, in contrast with urinary prohepcidin, was relatively consistent for the women between 0 and 16 wk. Serum prohepcidin correlated directly with serum ferritin (R2 = 0.28, P < 0.01) but was unrelated to 59Fe absorption, in contrast to serum ferritin (R2 = 0.33, P < 0.01).

Conclusions: Serum prohepcidin concentrations were relatively stable within subjects and correlated with serum ferritin. However, unlike serum ferritin, neither serum nor urinary prohepcidin concentrations were related to iron absorption in healthy women.

Key Words: Iron absorption • hepcidin • prohepcidin • iron status • serum ferritin • postmenopausal women




This article has been cited by other articles:


Home page
CJASNHome page
J. Zaritsky, B. Young, H.-J. Wang, M. Westerman, G. Olbina, E. Nemeth, T. Ganz, S. Rivera, A. R. Nissenson, and I. B. Salusky
Hepcidin--A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1051 - 1056.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. M. Fernandez-Real, F. Equitani, J. M. Moreno, M. Manco, F. Ortega, and W. Ricart
Study of Circulating Prohepcidin in Association with Insulin Sensitivity and Changing Iron Stores
J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 982 - 988.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. F Young, R. P Glahn, M. Ariza-Nieto, J. Inglis, G. Olbina, M. Westerman, and K. O O'Brien
Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women
Am. J. Clinical Nutrition, February 1, 2009; 89(2): 533 - 538.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. M Frazer and G. J Anderson
Hepcidin compared with prohepcidin: an absorbing story
Am. J. Clinical Nutrition, February 1, 2009; 89(2): 475 - 476.
[Full Text] [PDF]


Home page
J. Nutr.Home page
J. F. Collins, M. Wessling-Resnick, and M. D. Knutson
Hepcidin Regulation of Iron Transport
J. Nutr., November 1, 2008; 138(11): 2284 - 2288.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. T. Murphy, D. R. Witcher, P. Luan, and V. J. Wroblewski
Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry
Blood, August 1, 2007; 110(3): 1048 - 1054.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. M. Fernandez-Real, J. M. Moreno, B. Chico, A. Lopez-Bermejo, and W. Ricart
Circulating Visfatin Is Associated With Parameters of Iron Metabolism in Subjects With Altered Glucose Tolerance
Diabetes Care, March 1, 2007; 30(3): 616 - 621.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
C. Benedict, A. J. Ghio, H. Gehring, B. Schultes, A. Peters, and K. M. Oltmanns
Transient hypoxia and downregulation of circulating prohepcidin concentrations in healthy young men
Haematologica, January 1, 2007; 92(1): 125 - 126.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The American Society for Nutrition